Knowledge, practice and understanding of pictograms on medicines informing about prohibition and potential risks of their use during pregnancy.
DOI:
https://doi.org/10.35434/rcmhnaaa.2024.171.2210Keywords:
Patient Medication Knowledge, Comprehension, Pictograms, Medicine Package Inserts, Pregnant WomenAbstract
Background: Pictograms on medications aim to convey essential information, such as potential risks during pregnancy. However, their comprehension varies significantly based on the culture and health practices of each region. Objective: Evaluate the knowledge, practices, and understanding of pictograms warning about potential hazards associated with medication use during pregnancy in pregnant and non-pregnant women attending a reference Maternal Perinatal Institute in Peru. Method: Observational, cross-sectional study with non-random sampling. 409 women were surveyed regarding their knowledge of contraindicated medications during pregnancy, the presence of pictograms, frequency of reviewing package inserts, and interpretation of three U.S. approved pictograms from the Food and Drug Administration and the European Medicines Agency, used in products marketed in Peru. Results: 85% of participants knew about prohibited medications during pregnancy, but only 26.5% were aware of pictograms. Understanding the meaning of the pictograms, indicating "prohibited" or "risky during pregnancy," did not exceed 70%. 40.83% assigned an opposite meaning to the least understood pictogram. Reviewing drug leaflets was associated with higher education (p = 0.02) and having at least one child (p < 0.01). Conclusion: Low knowledge and a lack of understanding of pictograms conveying warnings about medication use during pregnancy highlight the need to improve their clarity on product labels. Further research is required to develop understandable pictograms, especially in culturally diverse settings.
Downloads
Metrics
References
Kassam, R, Vaillancourt, L.R.; Collins, J.B. Pictographic instructions for medications: Do different cultures interpret them accurately? Int. J. Pharm. Pract. 2004, 12, 199–209. https://doi.org/10.1211/0022357044698
Malhotra R, Tan YW, Suppiah SD, Tay SSC, Tan NC, Liu J, Koh GC, Chan A, Vaillancourt R; PROMISE Study Group. Pharmaceutical pictograms: User-centred redesign, selection and validation. PEC Innov. 2022;2:100-116. doi: 10.1016/j.pecinn.2022.100116.
Fonseca, R. Reading Pictograms and Signs—The Need for Visual Literacy. [Master’s Thesis]. Norway: University of Stavanger; 2011. https://uis.brage.unit.no/uis-xmlui/handle/11250/185396
Lupattelli A, Spigset O, Twigg MJ, et al Medication use in pregnancy: a crosssectional, multinational web-based study. BMJ Open 2014;4:e004365. doi: 10.1136/bmjopen-2013-004365
Opoku R, Yar DD, Botchwey CO. Self-medication among pregnant women in Ghana: A systematic review and meta-analysis. Heliyon. 2022;8(10):e10777. doi:10.1016/j.heliyon.2022.e10777
Girmaw F, Sendekie AK, Mesfin B, Kassaw AT. Self-medication practices among pregnant women in Ethiopia [published correction appears in J Pharm Policy Pract. 2023 Jul 27;16(1):95]. J Pharm Policy Pract. 2023;16(1):74. doi:10.1186/s40545-023-00584-7
Tassew WC, Ferede YA, Sisay Woldie S, et al. Self-medication practice and associated factors among pregnant women in Ethiopia: A systematic review and meta-analysis. SAGE Open Med. 2023;11:20503121231194429. doi:10.1177/20503121231194429
Alonso-Castro AJ, Ruiz-Padilla AJ, Ruiz-Noa Y, et al. Self-medication practice in pregnant women from central Mexico. Saudi Pharm J. 2018;26(6):886-890. doi:10.1016/j.jsps.2018.03.008
Nezvalová-Henriksen K, Spigset O, Nordeng H. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. Br J Obstet Gynecol. 2013;120(8):948-59. doi: 10.1111/1471-0528.12192
Hernández RK, Werler MM, Romitti P, Sun L, Anderka M. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol. 2012;206(3):228. e1-. e8. Doi: 10.1016/j.ajog.2011.11.019
Daw JR, Hanley GE, Greyson DL, et al . Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf 2011;20:895–902. doi: 10.1002/pds.2184
Newton GD, Pray WS, Popovich NG. New OTC drugs and devices 2002: a selective review. J Am Pharm Assoc (Wash). 2003;43(2):249-260. doi:10.1331/108658003321480768
Abduelkarem AR, Mustafa H. Use of Over-the-Counter Medication among Pregnant Women in Sharjah, United Arab Emirates. J Pregnancy. 2017;2017:4503793. doi:10.1155/2017/4503793
Ministerio de Sanidad Servicios Sociales e Igualdad BOE 177-2015-8343. Pag 62-952. https://www.boe.es/eli/es/rdlg/2015/07/24/1/dof/spa/pdf
Brucker MC, King TL. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule. J Midwifery Womens Health. 2017 May;62(3):308316. Doi: 10.1111/jmwh.12611
Ley de los productos farmacéuticos, dispositivos médicos y productos sanitarios 2009.https://www.gob.pe/institucion/congreso-de-la-republica/normas-legales/2813441-29459
Reglamento para el Registro, Control y Vigilancia Sanitaria de Productos Farmacéuticos, Dispositivos Médicos y Productos Sanitarios. Decreto Supremo Nº 016-2011-SA.
https://www.digemid.minsa.gob.pe/webDigemid/normas- legales/2011/decreto-supremo-no-016-2011-sa/
Normas legales. Resolución Ministerial . Decreto Supremo N° 018-2019-SA Reglamento de implementación. https://www.digemid.minsa.gob.pe/webDigemid/normas-legales/2019/decreto-supremo-n-018-2019-sa/
Directiva Administrativa N° 269-MINSA/2019/DGOS. Anexo 4. Pictogramas para UPSS.Consulta externa.
https://cdn.www.gob.pe/uploads/document/file/3432713/Resolución%20Min isterial%20N°%20527-2022-MINSA.pdf
Barros I, Alcántara T, Mezquita A, O Santos A, Paixao F, Lira D. The use of pictograms in the health care: a literature review. Res Social Adm Pharm. 2014;10(5):704-19. doi: 10.1016/j.sapharm.2013.11.002
Instituto Nacional Materno Perinatal. Anuario Estadístico 2021. Lima: Oficina de Estadística e Informática/INMP; 2022. Serie de Boletines estadísticos 2021. Disponible en: https://www.inmp.gob.pe/institucional/boletinesestadisticos/1422371837
Fórmula de cálculo de la muestra poblaciones finitas https://investigacionpediahr.files.wordpress.com/2011/01/formula-para-cc3a1lculo-de-la-muestra-poblaciones-finitas-var-categorica.pdf
Williams JR. The Declaration of Helsinki and public Health [en línea]. Bulletin of the World Health Organization. Public health classics. 2008, 86,8, Disponible en: http://www.who.int/bulletin/
US Food and Drug Administration. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. FDA drug safety. Communication, 2020 (10/15), 1-9. https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic
Iqbal MM, Sobhan T, Aftab SR, Mahmud SZ. Uso de diazepam durante el embarazo: una revisión de la literatura. Del Med J. 2002; 74(3):127-135. https://pubmed.ncbi.nlm.nih.gov/11963349/
Wang QQ, He CY, Mei J, Xu YL. Epidemiology of Birth Defects in Eastern China and the Associated Risk Factors. Med Sci Monit. 2022;28:e933782. doi: 10.12659/MSM.933782.
OMS. Directriz: Administración de suplementos de vitamina A en el embarazo. Ginebra, Organización Mundial de la Salud, 2011. https://iris.who.int/bitstream/handle/10665/44723/9789243501789_spa.pdf?ua=1
United States Pharmacopeia (USP) available https://www.usp.org/
European Medicines Agency and Heads of Medicines Agencies, Guideline on good pharmaco vigilance practices (GVP). 2019.
https://www.ema.europa.eu/en/documents/scientific-guideline/draft- guideline-good-pharmacovigilance-practices-product-or-population- specific-considerations-iii-pregnant-and-breastfeeding-women_en.pdf
Atmadani RN, Nkoka O, Yunita SL, Chen YH. Self-medication and knowledge among pregnant women attending primary healthcare services in Malang, Indonesia: a cross-sectional study. BMC Pregnancy Childbirth. 2020 Jan 16;20(1):42. doi: 10.1186/s12884-020-2736-2.
Berenguer M, Duester G. Retinoic acid, RARs and early development. J Mol Endocrinol. 2022 11;69(4):T59-T67. doi: 10.1530/JME-22-0041
Instituto Nacional Estadística e Informática. Perfil Socio-demográfico y Actividad Económica de las mujeres en edad fértil 2023. Lima: INEI; 2023. Disponible en: https://www.gob.pe/institucion/inei/informes-publicaciones/3364616-encuesta-demografica-y-de-salud-familiar-endes-2023
Organización Internacional de Estandarización 2019. accesible https://www.iso.org/obp/ui/es/#iso:grs:7010:P001
Medina-Córdoba M, Cadavid S, Pérez-Acosta AM, Amaya-Giraldo V. Factores que facilitan y dificultan la comprensión de los prospectos de información al paciente (PIL): una breve revisión exploratoria. Frente Pharmacol. 2021;12:740334. doi:10.3389/fphar.2021.740334
Pereira G, Surita FG, Ferracini AC, Madeira CS, Oliveira LS, Mazzola PG. Self-Medication Among Pregnant Women: Prevalence and Associated Factors. Front Pharmacol. 2021 Sep 6;12:659503. doi: 10.3389/fphar.2021.659503. Erratum in: Front Pharmacol. 2021 ;12:810762.
Beyene, K. G. M., and Beza, S. W. (2018). Self-medication Practice and Associated Factors Among Pregnant Women in Addis Ababa, Ethiopia. Trop. Med. Health 46 (1), 10. doi:10.1186/s41182-018-0091-z
Verstappen, G. M., Smolders, E. J., Munster, J. M., Aarnoudse, J. G., and Hak, E. (2013). Prevalence and Predictors of Over-the-counter Medication Use Among Pregnant Women: a Cross-Sectional Study in the Netherlands. BMC public health 13, 185. doi:10.1186/1471-2458-13-185
Bianchini BV, Curvello K, Giugliani C, da Silva Dal Pizzol T. Comprehension of Pictograms Demonstrating the Risk of Medication Use During Pregnancy: A Systematic Review. Matern Child Health J. 2022 Nov;26(11):2318-2338. doi: 10.1007/s10995-022-03549-5.
Bertrand D, Piedeloup I, Mattoug S, Liabeuf S,Gras-Champel V,Évaluation et impact des pictogrammes « grossesse » apposés sur les conditionnements extérieurs des médicaments : enquête auprès de 281 femmes, Therapies 2020, 75 (5), Pages 449-458. https://doi.org/10.1016/j.therap.2019.11.001
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 María Vargas-Huillcanina, Margot Quintana-Salinas, Rosa Pando-Alvarez, Maritza Placencia-Medina , Javier Silva-Valencia , Rocío Hermoza-Moquillaza, Carlos Saavedra-Levau
This work is licensed under a Creative Commons Attribution 4.0 International License.
